These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 7679777)

  • 1. Forensic evidence by DNA sequencing.
    Albert J; Wahlberg J; Uhlén M
    Nature; 1993 Feb; 361(6413):595-6. PubMed ID: 7679777
    [No Abstract]   [Full Text] [Related]  

  • 2. Human immunodeficiency virus. Playing chess with reverse transcriptase.
    Richman DD
    Nature; 1993 Feb; 361(6413):588-9. PubMed ID: 7679776
    [No Abstract]   [Full Text] [Related]  

  • 3. Potential animal model for AIDS.
    Science; 1995 Sep; 269(5232):1819, 1821. PubMed ID: 7569914
    [No Abstract]   [Full Text] [Related]  

  • 4. Sequence data as evidence.
    Holmes EC; Brown AJ; Simmonds P
    Nature; 1993 Aug; 364(6440):766. PubMed ID: 8355803
    [No Abstract]   [Full Text] [Related]  

  • 5. Primer selection by HIV-1 reverse transcriptase on RNA-tRNA(3Lys) and DNA-tRNA(3Lys) hybrids.
    Yusupova G; Lanchy JM; Yusupov M; Keith G; Le Grice SF; Ehresmann C; Ehresmann B; Marquet R
    J Mol Biol; 1996 Aug; 261(3):315-21. PubMed ID: 8780773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy.
    Chow YK; Hirsch MS; Merrill DP; Bechtel LJ; Eron JJ; Kaplan JC; D'Aquila RT
    Nature; 1993 Feb; 361(6413):650-4. PubMed ID: 7679778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A drug resistance mutation in the inhibitor binding pocket of human immunodeficiency virus type 1 reverse transcriptase impairs DNA synthesis and RNA degradation.
    Fan N; Rank KB; Slade DE; Poppe SM; Evans DB; Kopta LA; Olmsted RA; Thomas RC; Tarpley WG; Sharma SK
    Biochemistry; 1996 Jul; 35(30):9737-45. PubMed ID: 8703945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of heterogeneous viral populations by direct DNA sequencing.
    Leitner T; Halapi E; Scarlatti G; Rossi P; Albert J; Fenyö EM; Uhlén M
    Biotechniques; 1993 Jul; 15(1):120-7. PubMed ID: 8363827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interaction of primers with mutant forms of human immunodeficiency virus reverse transcriptase].
    Zakharova OD; Suturina OA; Gudima SO; Pokholok DK; Iamkovoĭ VI; Kochetkov SN; Nevinskiĭ GA
    Mol Biol (Mosk); 1996; 30(1):231-40. PubMed ID: 8714140
    [No Abstract]   [Full Text] [Related]  

  • 10. Interactions between drug resistance mutations in human immunodeficiency virus type 1 reverse transcriptase.
    Larder BA
    J Gen Virol; 1994 May; 75 ( Pt 5)():951-7. PubMed ID: 7513745
    [No Abstract]   [Full Text] [Related]  

  • 11. HIV-1 error revealed.
    Chow YK; Hirsch MS; Kaplan JC; D'Aquila RT
    Nature; 1993 Aug; 364(6439):679. PubMed ID: 7689174
    [No Abstract]   [Full Text] [Related]  

  • 12. Polymorphism and drug-selected mutations in the reverse transcriptase gene of HIV-2 from patients living in southeastern France.
    Colson P; Henry M; Tivoli N; Gallais H; Gastaut JA; Moreau J; Tamalet C
    J Med Virol; 2005 Mar; 75(3):381-90. PubMed ID: 15648062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and mutational analysis of the reverse transcriptase of the lentivirus equine infectious anemia virus.
    Shaharabany M; Rice NR; Hizi A
    Biochem Biophys Res Commun; 1993 Oct; 196(2):914-20. PubMed ID: 7694581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and purification of the HIV-1 reverse transcriptase using the baculovirus expression vector system.
    Kawa S; Kumar A; Smith JS; Becerra SP; Beard WA; Wilson SH; Thompson EB
    Protein Expr Purif; 1993 Aug; 4(4):298-303. PubMed ID: 7690627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitive procedure for the amplification of HIV-1 RNA using a combined reverse-transcription and amplification reaction.
    Nijhuis M; Boucher CA; Schuurman R
    Biotechniques; 1995 Aug; 19(2):178-80, 182. PubMed ID: 8527130
    [No Abstract]   [Full Text] [Related]  

  • 16. Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy.
    Devereux HL; Youle M; Johnson MA; Loveday C
    AIDS; 1999 Dec; 13(18):F123-7. PubMed ID: 10630517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of human immunodeficiency virus type 1 (HIV-1) infections: strategies to overcome drug resistance development.
    de Clercq E
    Med Res Rev; 1996 Mar; 16(2):125-57. PubMed ID: 8656777
    [No Abstract]   [Full Text] [Related]  

  • 18. Convergent combination therapy can select viable multidrug-resistant HIV-1 in vitro.
    Larder BA; Kellam P; Kemp SD
    Nature; 1993 Sep; 365(6445):451-3. PubMed ID: 7692302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of human immunodeficiency virus type 1 reverse transcriptase primer tRNA binding by fluorescence spectroscopy: specificity and comparison to primer/template binding.
    Thrall SH; Reinstein J; Wöhrl BM; Goody RS
    Biochemistry; 1996 Apr; 35(14):4609-18. PubMed ID: 8605212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of interactions of DNA polymerase beta and reverse transcriptases of human immunodeficiency and mouse leukemia viruses with dNTP analogs containing a modified sugar residue.
    Lebedeva NA; Seredina TA; Silnikov VN; Abramova TV; Levina AS; Khodyreva SN; Rechkunova NI; Lavrik OI
    Biochemistry (Mosc); 2005 Jan; 70(1):1-7. PubMed ID: 15701045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.